VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

TCT 2021 | Future directions of immune cell therapy in lymphoma

Yago Nieto, MD, PhD, University of Texas MD Anderson Cancer Center, Houston, TX, explores the next stages of immunotherapy and cellular therapy for patients with lymphoma, including the use of novel immune cells as well as improving the efficacy of T-cell approaches to prevent T-cell exhaustion and enhance T-cell localization. This interview took place during the Transplantation & Cellular Therapy (TCT) 2021 Meetings.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter